We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 7634X
GW Pharmaceuticals PLC
15 January 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ------------------------------------------------------------------------------------ 1. Identity of the issuer or the underlying GW Pharmaceuticals issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------ ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------ An acquisition or disposal of voting rights X --------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights --------------------------------------------------------------------------- ------- Other (please specify): ------------------ ------------------------------------------------------- ------- 3. Full name of person(s) subject to the notification obligation: (iii) M&G Investment Funds 3 ------------------------------------------ ---------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) State Street Noms Ltd A/C GMIQ ------------------------------------------ ---------------------------------------- 5. Date of the transaction and date 14 January 2014 on which the threshold is crossed or reached: (v) ------------------------------------------ ---------------------------------------- 6. Date on which issuer notified: 15 January 2014 ------------------------------------------ ---------------------------------------- 7. Threshold(s) that is/are crossed See item 13 or reached: (vi, vii) ------------------------------------------ ---------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------- ----------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ------------- --------------- --------------------- ------------- ------------------------- ----------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- --- --- ----- ------ ----- --- ------------- -------------- --------- --------------- ------------ GB0030544687 20,661,389 20,661,389 20,661,389 20,661,389 0 9.96% 0 ------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------ US36197T1034 615,000 7,380,000 840,000 10,080,000 0 4.86% 0 ------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------ B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ----------------------- ---------------- -------------------------------- ----------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------------ Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights instrument price date (xvii) Conversion rights instrument (xix, xx) period refers to (xviii) ------------------ ------------- ------------- ------------------ ------------------------------ ------------------------ Nominal Delta ------------------ ------------- ------------- ------------------ ------------------------------ ------------- --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------------------------ ---------------------------------------------------------- 30,741,389 14.82% ------------------------------------------------------------------ ---------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------------------- Proxy Voting: ----------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------ --------------------------------- 11. Number of voting rights proxy holder will N/A cease to hold: ------------------------------------------------------ --------------------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: ------------------------------------------------------ --------------------------------- With reference to item 3, M&G Investments 13. Additional information: Funds 3 is an Open Ended Investment Company (OEIC) and is not a Prudential group company and must be separately disclosed. This OEIC Fund is managed by M&G Investment Management Limited (a wholly owned subsidiary of Prudential plc) and will have been previously attributed to Prudential plc solely on the basis that M&G Investment Management Ltd has direct fund management control over the shares identified in this notification. Therefore the 14.82% holding being disclosed in this notification is encompassed in the 14.82% being disclosed under The Prudential plc group of companies and is NOT in addition to it. ---------------------------------------- ----------------------------------------------- 14. Contact name: James Todd / Mark Thomas M&G Investment Management Limited ---------------------------------------- ----------------------------------------------- 15. Contact telephone number: 020 7548 2293 / 020 7548 3266 ---------------------------------------- -----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKFSFDALEFF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions